PharmGKB summary

This publication has 90 references indexed in Scilit:

• Refining the UGT1A Haplotype Associated with Irinotecan-Induced Hematological Toxicity in Metastatic Colorectal Cancer Patients Treated with 5-Fluorouracil/Irinotecan-Based Regimens
  The Journal of Pharmacology and Experimental Therapeutics, 2013
• Association between bilirubin and cardiovascular disease risk factors: using Mendelian randomization to assess causal inference
  BMC Cardiovascular Disorders, 2012
• Eponym
  European Journal of Pediatrics, 2011
• Serum Bilirubin Links UGT1A1*28 Polymorphism and Predicts Long-Term Cardiovascular Events and Mortality in Chronic Hemodialysis Patients
  Clinical Journal of the American Society of Nephrology, 2011
• Cost effectiveness of pharmacogenetic testing for uridine diphosphate glucuronosyltransferase 1A1 before irinotecan administration for metastatic colorectal cancer
  Cancer, 2009
• Predictive Role of the UGT1A1, UGT1A7, and UGT1A9 Genetic Variants and Their Haplotypes on the Outcome of Metastatic Colorectal Cancer Patients Treated With Fluorouracil, Leucovorin, and Irinotecan
  Journal of Clinical Oncology, 2009
• UGT1A1*6 polymorphism is most predictive of severe neutropenia induced by irinotecan in Japanese cancer patients
  International Journal of Clinical Oncology, 2009
• Effects of UGT1A1*28 polymorphism on raloxifene pharmacokinetics and pharmacodynamics
  British Journal of Clinical Pharmacology, 2009
• Clinical Significance of UDP-Glucuronosyltransferase 1A1*6 for Toxicities of Combination Chemotherapy with Irinotecan and Cisplatin in Gynecologic Cancers
  Oncology, 2009
• Glucuronidation of 7-Ethyl-10-hydroxycamptothecin (SN-38) by the Human UDP-Glucuronosyltransferases Encoded at the UGT1 Locus
  Biochemical and Biophysical Research Communications, 1999